Correction: Incidence and risk of hematologic toxicities in cancer patients treated with regorafenib
Metrics: PDF 805 views | ?
1 Center for Scientific Research, The Second Affiliated Hospital & Yuying Children’s Hospital, Wenzhou Medical University, Wenzhou, 325027, China
2 Department of Medical Oncology, The Third Affiliated Hospital of Harbin Medical University, Harbin, 150081, China
Published: January 04, 2019
This article has been corrected: The correct author affiliation information is given below:
Original article: Oncotarget. 2017; 8:93813-93824. DOI: https://doi.org/10.18632/oncotarget.21217.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.